Blueprint Medicines
BPMC
83,18 €
Share price
-1.09%
Change (1 day)
-5.11%
Change (1 year)
Categories
Blueprint Medicines (BPMC) - Total liabilities
Total liabilities on the balance sheet as of December 2024 : €0.81 Billion
According to Blueprint Medicines 's latest financial reports the company's total liabilities are €0.81 Billion. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Blueprint Medicines - Total liabilities on balance sheet (from 2014 to 2024)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2024-12-31 | €0.84 B | 1.9% |
| 2023-12-31 | €0.83 B | 6.73% |
| 2022-12-31 | €0.77 B | 213.27% |
| 2021-12-31 | €0.24 B | 23.12% |
| 2020-12-31 | €0.20 B | -7.06% |
| 2019-12-31 | €0.21 B | 105.17% |
| 2018-12-31 | €0.10 B | 38.43% |
| 2017-12-31 | €76.48 M | 15.39% |
| 2016-12-31 | €66.28 M | 107.54% |
| 2015-12-31 | €31.93 M | 167.94% |
| 2014-12-31 | €11.91 M | 192.32% |
| 2013-12-31 | €4.07 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 | €3.03 M | -99.63% | 🇺🇸 USA |
 | €0.77 B | -5.26% | 🇺🇸 USA |
 | €0.69 B | -14.45% | 🇺🇸 USA |